Pharmaceutical Applications of Cannabinoids
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: 25 June 2026
Special Issue Editors
Interests: organic chemistry; analytical chemistry; mass spectrometry; natural products; heterocyclic compounds
Special Issues, Collections and Topics in MDPI journals
Interests: cannabis; psychedelics; analytical chemistry; medicinal chemistry; drug delivery systems
Special Issue Information
Cannabis is increasingly recognized by society not only as one of the most widely used illegal substances but, more importantly, for its therapeutic potential. The approval of Δ9-THC and CBD-containing formulations by regulatory agencies like the FDA and EMA has led to an expansion of new pharmaceutical and other formulated products, broadening their biomedical applications. Alongside these medical advances, the growth of cannabis-based products is remarkable, reaching areas such as cosmetics, food products, supplements, and beverages.
The aim of this Special Issue is to update and report several aspects of the pharmaceutical applications of cannabinoids and their derivatives, focusing on important therapeutic areas such as the following:
- delivery methods and novel formulations;
- challenges concerning standardization and bioavailability;
- psychoactive side effects, and drug–drug interactions;
- applications in pain management, neurological and psychiatric disorders, dermatological applications, sleep disorders, etc.
Prof. Dr. Eduarda M. P. Silva
Dr. Carlos Ribeiro
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cannabis
- cannabinoids
- therapeutic properties
- medicinal plant
- phytochemicals
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
